Cancer can cause weakness in the legs through a surprisingly wide range of mechanisms, from tumors pressing directly on the spinal cord to immune reactions that attack nerve connections far from any tumor site. The weakness may come from the disease itself, from its treatment, or from the body’s systemic response to advanced illness. Because several of these causes are treatable or even reversible when caught early, understanding why your legs feel weak matters more than most people realize.
Spinal Cord Compression Is the Most Urgent Cause
When cancer spreads to the spine, tumor growth in the space around the spinal cord can physically squeeze the cord or cut off its blood supply. This condition, called metastatic spinal cord compression, is considered a medical emergency. Progressive leg weakness is one of its hallmark symptoms, typically alongside back pain, changes in sensation, and sometimes loss of bladder or bowel control.1PubMed Central. Metastatic spinal cord compression: a rare but important complication of cancer
The reason urgency matters here is practical: whether you can still walk at the time treatment begins is one of the strongest predictors of whether you will walk afterward. People who lose the ability to stand before treatment starts have a much lower chance of regaining it. That makes any new or worsening leg weakness in someone with a known cancer diagnosis something to report immediately, not something to wait out over a few days.
Brain Tumors and Metastases That Affect Motor Areas
The brain controls voluntary movement through specific regions, and tumors in or near those areas can produce weakness on one or both sides of the body. Motor deficits including weakness, loss of coordination, spasticity, and trouble executing complex movements can occur at any point during a brain tumor illness.2PubMed Central. Clinical implications of motor deficits related to brain tumors The leg weakness tends to affect one side more than the other, depending on which hemisphere the tumor occupies, though bilateral involvement is possible.
Brain metastases are common in cancers that start elsewhere in the body. In one surgical series, over half of patients with brain metastases had tumors located in or near a motor area such as the primary motor cortex, the supplementary motor area, the corticospinal tract, or the cerebellum.3Neuro-Oncology Practice. Survival, quality of life, and motor function in brain metastases surgery: The role of complete resection Yet most people with metastases in these motor regions do not necessarily present with obvious weakness right away. In a study of patients with metastases specifically in the primary motor cortex who were treated with focused radiation, roughly four out of five had no motor deficit at the time of treatment, while about one in five had mild to moderate weakness.4PubMed. Tumor control and motor function in patients with metastases located in the primary motor cortex after stereotactic radiosurgery Of those who did have weakness, the majority improved after treatment. The takeaway is that brain metastases near motor areas are worth monitoring closely, but weakness is not inevitable and can sometimes be reversed.
Cancer Spreading Along Nerves in the Pelvis and Lower Spine
Pelvic cancers including prostate, bladder, rectal, and cervical cancers have a particular ability to spread along nerve pathways. Tumor cells can infiltrate the autonomic nerve network in the pelvis and travel along those nerve fibers to reach the lumbosacral plexus, the bundle of nerves that supplies sensation and motor control to the legs.5Neurosurgical Focus. Perineural spread of pelvic malignancies to the lumbosacral plexus and beyond: clinical and imaging patterns From the plexus, cancer can continue spreading along branching nerves toward the limbs or back up toward the spinal nerve roots.
When this happens, the typical pattern is severe pain that radiates from the lower back down into the legs, followed over time by progressive weakness.6PubMed. Neoplastic lumbosacral radiculoplexopathy in prostate cancer by direct perineural spread: an unusual entity This kind of nerve-based leg weakness can be confusing to diagnose because it mimics common non-cancerous conditions like sciatica or a herniated disc. The pain often comes first, and the weakness develops gradually, so both patients and doctors can initially attribute it to something more routine.
A related scenario occurs when cancer spreads to the membranes surrounding the spinal cord and nerve roots, a condition called leptomeningeal disease. When this affects the lower portion of the spine, it can compress the cauda equina, the fan of nerve roots at the base of the spinal column. The result is bilateral leg weakness, numbness, and often bowel or bladder problems.7PubMed Central. Cauda Equina Syndrome Secondary to Leptomeningeal Carcinomatosis of Gastroesophageal Junction Cancer In one reported case, a patient with a gastrointestinal cancer developed hip pain followed by mild weakness in one leg that gradually worsened and spread to both legs.8ecancermedicalscience. Cauda equina syndrome secondary to leptomeningeal metastases from recurrent primary peritoneal carcinoma Like spinal cord compression, cauda equina syndrome is treated as an emergency because delays reduce the chance of recovery.
When the Immune System Attacks the Nerves Instead of the Tumor
Some cancers trigger the immune system to produce antibodies that mistakenly target healthy tissues, including the neuromuscular junction where nerves communicate with muscles. This is the basis of paraneoplastic syndromes, and the most common one affecting leg strength is Lambert-Eaton myasthenic syndrome, or LEMS.
LEMS causes weakness that is most noticeable in the muscles closest to the trunk: the thighs, hips, and upper arms. People with LEMS often describe difficulty rising from a chair, climbing stairs, or walking. It typically comes with diminished reflexes and symptoms of autonomic dysfunction like dry mouth. In a review of reported cases, proximal leg weakness was the most common presenting symptom, appearing in about 60% of patients, and proximal muscle weakness in general was reported in over 90%.9PubMed Central. Lambert-Eaton Myasthenic Syndrome in Lung Cancer
What makes LEMS particularly notable is that it often appears before the cancer is found. Between 40% and 62% of people diagnosed with LEMS turn out to have small-cell lung cancer, and in almost all of those cases, the neurological symptoms showed up before anyone knew about the tumor.10PubMed Central. The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma The weakness can be subtle at first, leading to delayed diagnosis. Because LEMS can be the first sign something is wrong, unexplained progressive weakness in the thighs and hips, especially when combined with reduced reflexes, warrants investigation for an underlying cancer.11Academic Medicine & Surgery. Paraneoplastic Lambert-Eaton Myasthenic Syndrome Unveiling Occult Small-Cell Lung Carcinoma: A Case Report
Treatment-Related Leg Weakness
Cancer treatments themselves are a major source of leg weakness, and the effects sometimes persist long after treatment ends. The three most common treatment-related culprits are chemotherapy-induced nerve damage, radiation injury, and steroid medications.
Chemotherapy-Induced Peripheral Neuropathy
Certain chemotherapy drugs, particularly taxanes and platinum-based agents, are toxic to peripheral nerves. The resulting condition causes numbness, tingling, and distal weakness, meaning it affects the hands and feet first. In children and young adults, this neuropathy has been shown to impair dexterity, gait, and balance, and similar effects occur in older patients.12PubMed. Impact of chemotherapy-induced peripheral neuropathy on physical function in pediatric cancer survivors: a systematic review Among breast cancer survivors treated with taxane-based chemotherapy, those with persistent neuropathy showed reductions in gait speed and stride length, both of which are critical indicators of fall risk.13Innovation in Aging. Gait Parameters in Older Breast Cancer Survivors with Persistent Chemotherapy-Induced Peripheral Neuropathy
The insidious part is the word “persistent.” For a substantial number of people, the neuropathy does not fully resolve when chemotherapy ends. Walking feels less stable, feet feel numb or tingly, and the legs feel weaker than before treatment. This can continue for months or years.
Radiation-Induced Nerve Damage
Radiation therapy directed at the pelvis can injure the lumbosacral plexus, producing a delayed form of leg weakness that sometimes appears weeks to months after treatment. The clinical picture includes bilateral leg pain, reduced sensation, varying degrees of weakness, and in severe cases, paralysis. In one reported case of a woman treated for cervical cancer, neurological symptoms began a few weeks after completing radiation and gradually escalated until she was completely immobilized.14PubMed Central. Radiotherapy-induced lumbosacral plexopathy in a patient with cervical cancer: a case report and literature review While this outcome is rare, it illustrates the potential severity of radiation-induced nerve injury.
This kind of delayed plexopathy can start on one side and progress to affect both legs. It mimics radiculopathy from a disc problem, which can lead doctors down the wrong diagnostic path initially.15Radiation. Unilateral to Bilateral Lumbosacral Plexopathy After Radiation Therapy: A Case Report A history of pelvic radiation is the key piece of clinical context that distinguishes it.
Steroid-Related Muscle Weakness
Corticosteroids like dexamethasone are used heavily in cancer care to reduce swelling around tumors, manage nausea, and treat various complications. But prolonged use causes a well-recognized form of muscle weakness concentrated in the muscles closest to the trunk: the thighs, shoulders, and hips. In a prospective study of cancer patients treated with steroids, 60% developed clinically detectable proximal muscle weakness, and in the majority, it appeared within two weeks of starting treatment. In about two-thirds of those who developed weakness, it was severe enough to interfere with daily activities.16PubMed. Steroid myopathy in cancer patients
In patients with primary brain tumors who received at least two continuous weeks of daily dexamethasone, about one in ten developed significant steroid-related muscle weakness.17PubMed. Steroid-induced weakness in patients with primary brain tumors This form of weakness is reversible once the steroid dose is reduced, but distinguishing it from weakness caused by the tumor itself can be difficult in real time.
Cancer Cachexia and General Muscle Wasting
Beyond all the specific structural and neurological causes, advanced cancer produces a systemic state of muscle breakdown known as cachexia. This is not simply losing weight from poor appetite. It involves active biological processes that degrade muscle tissue and impair how remaining muscle functions. The weakness comes from both reduced muscle mass and reduced muscle quality.18PubMed Central. Cancer-associated muscle weakness: What’s bone got to do with it?
Research has shown that cancer and chemotherapy together can disrupt the connections between motor nerves and muscle fibers. Changes at the neuromuscular junction, where the nerve signals the muscle to contract, appear to contribute to the wasting and weakness that cancer patients experience.19PubMed Central. Muscle weakness caused by cancer and chemotherapy is associated with loss of motor unit connectivity This means the weakness of cachexia is not only about shrinking muscles; the wiring between nerve and muscle deteriorates as well.
When cancer has spread to bone, an additional mechanism appears to be at play. Tumor cells in bone stimulate excessive bone breakdown, which releases growth factors stored in the bone matrix. Emerging evidence suggests these bone-derived factors can travel through the bloodstream and directly impair muscle function at distant sites.18PubMed Central. Cancer-associated muscle weakness: What’s bone got to do with it? This could explain why some patients with bone metastases experience generalized weakness out of proportion to what the local tumor burden alone would predict.
Bone Metastases and Structural Failure
Cancer that spreads to the bones of the leg, particularly the femur, creates a different kind of problem. Rather than attacking nerves or muscles, it weakens the structural integrity of the bone itself. Patients with bone metastases in the femur carry a real risk of pathological fracture, where the bone breaks under normal weight-bearing stress because the tumor has hollowed it out from the inside. Finite element analysis of femurs with metastatic disease has confirmed that tumor-affected areas show dramatically higher strain under the forces of normal standing compared to healthy bone.20PubMed. Pathological fracture risk assessment in patients with femoral metastases using CT-based finite element methods
Before a fracture actually occurs, the weakened bone can produce pain and functional limitation that the patient experiences as leg weakness, even though the nerves and muscles may be intact. Walking becomes guarded, the gait changes, and bearing weight feels unreliable. When fractures do occur, surgical reconstruction with specialized prostheses is often required to restore any mobility.21PubMed Central. Prosthetic joint replacement for femoral bone metastases and pathological fracture: A retrospective case series study of cases within the past 10 years
Blood Clots and Vascular Causes
Cancer significantly increases the risk of blood clots. Solid tumors confer roughly a two-fold increase in arterial thromboembolism compared to people without cancer.22PubMed Central. Arterial Thrombosis in Patients with Cancer Deep vein thrombosis in the legs is even more common. In a study of advanced cancer patients who presented with lower extremity swelling, 44% had a positive scan for deep vein thrombosis.23PubMed. Deep vein thrombosis (DVT) in advanced cancer patients with lower extremity edema referred for assessment
A DVT in the leg typically causes swelling, pain, and heaviness rather than true muscle weakness. But significant leg swelling impairs mobility and can make the leg feel heavy and difficult to move. In advanced cancer patients, the edema is often bilateral and asymmetric, which can look and feel different from a classic single-leg DVT. And if an arterial clot blocks blood flow to the leg or triggers a stroke affecting motor areas of the brain, genuine weakness follows. The point is that vascular complications are a real and underappreciated contributor to impaired leg function in cancer patients.
When the Cause Gets Missed
One of the frustrating realities of cancer-related leg weakness is how easily the underlying cause can be misidentified, especially when the cancer is not yet known or when the metastasis is in an unusual location. A case report of a 67-year-old woman illustrates this well: she presented with lower back pain and progressive difficulty walking, and imaging suggested a common age-related narrowing of the spinal canal. In fact, the cause was a metastatic melanoma that had spread to the lumbar spine 13 years after her original vulvar melanoma was removed. The long gap between the original cancer and the spinal metastasis, combined with the tumor’s unusual appearance on imaging, delayed the correct diagnosis.24PubMed Central. Easily misdiagnosed delayed metastatic intraspinal extradural melanoma of the lumbar spine: A case report and review of the literature
Similarly, lower limb weakness from Lambert-Eaton syndrome can be mistakenly attributed to peripheral neuropathy, especially in patients who also have diabetes.9PubMed Central. Lambert-Eaton Myasthenic Syndrome in Lung Cancer And radiation-induced plexopathy can look like disc disease. The common thread is that cancer-related leg weakness often presents in ways that overlap with far more common conditions, and the cancer connection is easy to overlook unless someone is specifically considering it.
Falls, Fear of Falling, and Rehabilitation
Beyond the medical causes of weakness, there is a significant psychological and functional dimension. Cancer patients undergoing chemotherapy show reduced balance, slower gait speed, and lower leg strength compared to healthy people of the same age. Their physical performance has been shown to resemble that of healthy adults over 65, regardless of their actual age.25PubMed. Functional capacity and fear of falling in cancer patients undergoing chemotherapy On top of the physical deficits, many develop a pronounced fear of falling, which compounds the problem. Research in older cancer patients with chemotherapy-induced neuropathy has shown that those who also feared falling had even worse gait performance than those with neuropathy alone, suggesting the fear itself contributes to physical decline.26PubMed Central. The detrimental association between fear of falling and motor performance in older cancer patients with chemotherapy-induced peripheral neuropathy
Physical therapy can interrupt this cycle. Structured rehabilitation programs across the cancer care continuum have been shown to reduce pain, fatigue, and deconditioning while improving mobility and quality of life.27PubMed Central. Exploring the Impact of Physical Therapy on Patient Outcomes Across the Cancer Care Continuum: A Narrative Review For many people dealing with cancer-related leg weakness, rehabilitation is not a luxury or an afterthought. It is the intervention most likely to help them stay on their feet, maintain independence, and avoid the secondary complications that come with immobility.